CRBP - CIK 0001595097
The table below shows Corbus Pharmaceuticals Holdings, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $28.49M | $17.20M | $13.72M | $17.00M | $25.01M | $85.43M |
| Short-term investments | $134.78M | $131.86M | $7.18M | $42.19M | $72.64M | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $166.95M |
| $152.98M |
| $23.55M |
| $60.18M |
| $100.20M |
| $92.07M |
| Property, plant & equipment | $159.00K | $385.00K | $973.21K | $1.61M | $2.39M | $4.07M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $168.19M | $155.88M | $28.27M | $66.31M | $107.73M | $102.29M |
| Accounts payable | $2.21M | $4.79M | $3.18M | $2.17M | $1.78M | $7.38M |
| Total current liabilities | $20.69M | $11.82M | $31.89M | $12.64M | $17.01M | $31.90M |
| Long-term debt | - | - | $0.00 | $15.98M | $15.64M | $18.03M |
| Total liabilities | $20.69M | $13.45M | $35.18M | $33.32M | $38.62M | $57.02M |
| Retained earnings | -$555.43M | -$476.89M | -$436.68M | -$392.08M | -$349.73M | -$304.09M |
| Total equity | $147.50M | $142.43M | -$6.90M | $32.99M | $69.11M | $45.27M |